# | Title | Journal | Year | Citations |
---|
1 | International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma | Journal of Thoracic Oncology | 2011 | 4,127 |
2 | The 2015 World Health Organization Classification of Lung Tumors | Journal of Thoracic Oncology | 2015 | 3,313 |
3 | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the TNM Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours | Journal of Thoracic Oncology | 2007 | 3,185 |
4 | The IASLC Lung Cancer Staging Project: Proposals for Revision of the TNM Stage Groupings in the Forthcoming (Eighth) Edition of the TNM Classification for Lung Cancer | Journal of Thoracic Oncology | 2016 | 3,162 |
5 | Receiver Operating Characteristic Curve in Diagnostic Test Assessment | Journal of Thoracic Oncology | 2010 | 2,415 |
6 | Introduction to The 2015 World Health Organization Classification of Tumors of the Lung, Pleura, Thymus, and Heart | Journal of Thoracic Oncology | 2015 | 1,301 |
7 | A Prospective, Molecular Epidemiology Study of EGFR Mutations in Asian Patients with Advanced Non–Small-Cell Lung Cancer of Adenocarcinoma Histology (PIONEER) | Journal of Thoracic Oncology | 2014 | 1,131 |
8 | Pulmonary Pathology of Early-Phase 2019 Novel Coronavirus (COVID-19) Pneumonia in Two Patients With Lung Cancer | Journal of Thoracic Oncology | 2020 | 1,110 |
9 | PD-L1 Immunohistochemistry Assays for Lung Cancer: Results from Phase 1 of the Blueprint PD-L1 IHC Assay Comparison Project | Journal of Thoracic Oncology | 2017 | 1,067 |
10 | The IASLC Lung Cancer Staging Project: A Proposal for a New International Lymph Node Map in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer | Journal of Thoracic Oncology | 2009 | 1,050 |
11 | The IASLC Lung Cancer Staging Project: Proposals for Revision of the M Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification of Lung Cancer | Journal of Thoracic Oncology | 2007 | 895 |
12 | Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study | Journal of Thoracic Oncology | 2007 | 882 |
13 | Molecular Testing Guideline for Selection of Lung Cancer Patients for EGFR and ALK Tyrosine Kinase Inhibitors: Guideline from the College of American Pathologists, International Association for the Study of Lung Cancer, and Association for Molecular Pathology | Journal of Thoracic Oncology | 2013 | 792 |
14 | The International Epidemiology of Lung Cancer: Geographical Distribution and Secular Trends | Journal of Thoracic Oncology | 2008 | 671 |
15 | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the T Descriptors in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer | Journal of Thoracic Oncology | 2007 | 658 |
16 | Checkpoint Inhibitors in Metastatic EGFR- Mutated Non–Small Cell Lung Cancer—A Meta-Analysis | Journal of Thoracic Oncology | 2017 | 653 |
17 | The IASLC Lung Cancer Staging Project: Proposals for the Revisions of the T Descriptors in the Forthcoming Eighth Edition of the TNM Classification for Lung Cancer | Journal of Thoracic Oncology | 2015 | 628 |
18 | PD-L1 Immunohistochemistry Comparability Study in Real-Life Clinical Samples: Results of Blueprint Phase 2 Project | Journal of Thoracic Oncology | 2018 | 589 |
19 | Local Ablative Therapy of Oligoprogressive Disease Prolongs Disease Control by Tyrosine Kinase Inhibitors in Oncogene-Addicted Non–Small-Cell Lung Cancer | Journal of Thoracic Oncology | 2012 | 585 |
20 | The IASLC Lung Cancer Staging Project: Validation of the Proposals for Revision of the T, N, and M Descriptors and Consequent Stage Groupings in the Forthcoming (Seventh) Edition of the TNM Classification of Malignant Tumours | Journal of Thoracic Oncology | 2007 | 568 |
21 | The International Association for the Study of Lung Cancer Lung Cancer Staging Project | Journal of Thoracic Oncology | 2015 | 550 |
22 | Does Lung Adenocarcinoma Subtype Predict Patient Survival?: A Clinicopathologic Study Based on the New International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Lung Adenocarcinoma Classification | Journal of Thoracic Oncology | 2011 | 535 |
23 | Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation | Journal of Thoracic Oncology | 2015 | 534 |
24 | The IASLC Lung Cancer Staging Project: Proposals for Coding T Categories for Subsolid Nodules and Assessment of Tumor Size in Part-Solid Tumors in the Forthcoming Eighth Edition of the TNM Classification of Lung Cancer | Journal of Thoracic Oncology | 2016 | 530 |
25 | The Long Noncoding MALAT-1 RNA Indicates a Poor Prognosis in Non-small Cell Lung Cancer and Induces Migration and Tumor Growth | Journal of Thoracic Oncology | 2011 | 515 |
26 | Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC | Journal of Thoracic Oncology | 2018 | 515 |
27 | The IASLC Lung Cancer Staging Project: Proposals for the Revision of the N Descriptors in the Forthcoming Seventh Edition of the TNM Classification for Lung Cancer | Journal of Thoracic Oncology | 2007 | 505 |
28 | A Prospective Radiological Study of Thin-Section Computed Tomography to Predict Pathological Noninvasiveness in Peripheral Clinical IA Lung Cancer (Japan Clinical Oncology Group 0201) | Journal of Thoracic Oncology | 2011 | 505 |
29 | The International Association for the Study of Lung Cancer Lung Cancer Staging Project: Proposals Regarding the Clinical Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the Tumor, Node, Metastasis Classification for Lung Cancer | Journal of Thoracic Oncology | 2007 | 503 |
30 | The Role of Tumor Stroma in Cancer Progression and Prognosis: Emphasis on Carcinoma-Associated Fibroblasts and Non-small Cell Lung Cancer | Journal of Thoracic Oncology | 2011 | 502 |
31 | The International Epidemiology of Lung Cancer: Latest Trends, Disparities, and Tumor Characteristics | Journal of Thoracic Oncology | 2016 | 485 |
32 | Primary Tumor Standardized Uptake Value (SUVmax) Measured on Fluorodeoxyglucose Positron Emission Tomography (FDG-PET) is of Prognostic Value for Survival in Non-small Cell Lung Cancer (NSCLC): A Systematic Review and Meta-Analysis (MA) by the European Lung Cancer Working Party for the IASLC Lung Cancer Staging Project | Journal of Thoracic Oncology | 2008 | 466 |
33 | The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes | Journal of Thoracic Oncology | 2015 | 463 |
34 | EML4-ALK Fusion Is Linked to Histological Characteristics in a Subset of Lung Cancers | Journal of Thoracic Oncology | 2008 | 441 |
35 | Trends in Stage Distribution for Patients with Non-small Cell Lung Cancer: A National Cancer Database Survey | Journal of Thoracic Oncology | 2010 | 437 |
36 | Epidemiology of Thymoma and Associated Malignancies | Journal of Thoracic Oncology | 2010 | 437 |
37 | The IASLC Lung Cancer Staging Project: Proposals Regarding the Relevance of TNM in the Pathologic Staging of Small Cell Lung Cancer in the Forthcoming (Seventh) Edition of the TNM Classification for Lung Cancer | Journal of Thoracic Oncology | 2009 | 435 |
38 | The 2021 WHO Classification of Lung Tumors: Impact of Advances Since 2015 | Journal of Thoracic Oncology | 2022 | 429 |
39 | Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas | Journal of Thoracic Oncology | 2015 | 428 |
40 | A Phase II Study of Pembrolizumab in EGFR-Mutant, PD-L1+, Tyrosine Kinase Inhibitor Naïve Patients With Advanced NSCLC | Journal of Thoracic Oncology | 2018 | 426 |
41 | Cancer of the Esophagus and Esophagogastric Junction: An Eighth Edition Staging Primer | Journal of Thoracic Oncology | 2017 | 424 |
42 | Gefitinib Treatment in EGFR Mutated Caucasian NSCLC: Circulating-Free Tumor DNA as a Surrogate for Determination of EGFR Status | Journal of Thoracic Oncology | 2014 | 416 |
43 | Analysis of Circulating Tumor Cells in Patients with Non-small Cell Lung Cancer Using Epithelial Marker-Dependent and -Independent Approaches | Journal of Thoracic Oncology | 2012 | 411 |
44 | Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors | Journal of Thoracic Oncology | 2018 | 408 |
45 | Activity of Crizotinib (PF02341066), a Dual Mesenchymal-Epithelial Transition (MET) and Anaplastic Lymphoma Kinase (ALK) Inhibitor, in a Non-small Cell Lung Cancer Patient with De Novo MET Amplification | Journal of Thoracic Oncology | 2011 | 407 |
46 | The Role of Tumor-Infiltrating Lymphocytes in Development, Progression, and Prognosis of Non–Small Cell Lung Cancer | Journal of Thoracic Oncology | 2016 | 401 |
47 | A Randomized, Placebo-Controlled Trial of Pembrolizumab Plus Chemotherapy in Patients With Metastatic Squamous NSCLC: Protocol-Specified Final Analysis of KEYNOTE-407 | Journal of Thoracic Oncology | 2020 | 395 |
48 | A Japanese Lung Cancer Registry Study: Prognosis of 13,010 Resected Lung Cancers | Journal of Thoracic Oncology | 2008 | 391 |
49 | microRNAs Derived from Circulating Exosomes as Noninvasive Biomarkers for Screening and Diagnosing Lung Cancer | Journal of Thoracic Oncology | 2013 | 391 |
50 | The International Association for the Study of Lung Cancer Staging Project: Prognostic Factors and Pathologic TNM Stage in Surgically Managed Non-small Cell Lung Cancer | Journal of Thoracic Oncology | 2009 | 387 |